|
1
|
Pui CH, Carroll WL, Meshinchi S and Arceci
RJ: Biology, risk stratification, and therapy of pediatric acute
leukemias: An update. J Clin Oncol. 29:551–565. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hunger SP, Lu X, Devidas M, Camitta BM,
Gaynon PS, Winick NJ, Reaman GH and Carroll WL: Improved survival
for children and adolescents with acute lymphoblastic leukemia
between 1990 and 2005: A report from the children's oncology group.
J Clin Oncol. 30:1663–1669. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Locatelli F, Schrappe M, Bernardo ME and
Rutella S: How I treat relapsed childhood acute lymphoblastic
leukemia. Blood. 120:2807–2816. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bhojwani D and Pui CH: Relapsed childhood
acute lymphoblastic leukaemia. Lancet Oncol. 14:e205–e217. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pui CH, Mullighan CG, Evans WE and Relling
MV: Pediatric acute lymphoblastic leukemia: Where are we going and
how do we get there? Blood. 120:1165–1174. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Huang X, Le QT and Giaccia AJ:
MiR-210-micromanager of the hypoxia pathway. Trends Mol Med.
16:230–237. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Devlin C, Greco S, Martelli F and Ivan M:
miR-210: More than a silent player in hypoxia. IUBMB Life.
63:94–100. 2011.PubMed/NCBI
|
|
8
|
Crosby ME, Kulshreshtha R, Ivan M and
Glazer PM: MicroRNA regulation of DNA repair gene expression in
hypoxic stress. Cancer Res. 69:1221–1229. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chan SY and Loscalzo J: MicroRNA-210: A
unique and pleiotropic hypoxamir. Cell Cycle. 9:1072–1083. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mei Y, Gao C, Wang K, Cui L, Li W, Zhao X,
Liu F, Wu M, Deng G, Ding W, et al: Effect of microRNA-210 in
prognosis and response to chemotherapeutic drugs in pediatric acute
lymphoblastic leukemia. Cancer Sci. 105:463–472. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Barcaroli D, Dinsdale D, Neale MH,
Bongiorno-Borbone L, Ranalli M, Munarriz E, Sayan AE, McWilliam JM,
Smith TM, Fava E, et al: FLASH is an essential component of Cajal
bodies. Proc Natl Acad Sci USA. 103:pp. 14802–14807. 2006,
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Barcaroli D, Bongiorno-Borbone L,
Terrinoni A, Hofmann TG, Rossi M, Knight RA, Matera AG, Melino G
and De Laurenzi V: FLASH is required for histone transcription and
S-phase progression. Proc Natl Acad Sci USA. 103:pp. 14808–14812.
2006, View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen S, Evans HG and Evans DR: FLASH
knockdown sensitizes cells to Fas-mediated apoptosis via
down-regulation of the anti-apoptotic proteins, MCL-1 and Cflip
short. PLoS One. 7:e329712012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Flotho C, Coustan-Smith E, Pei D, Iwamoto
S, Song G, Cheng C, Pui CH, Downing JR and Campana D: Genes
contributing to minimal residual disease in childhood acute
lymphoblastic leukemia: Prognostic significance of CASP8AP2. Blood.
108:1050–1057. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kim HW, Haider HK, Jiang S and Ashraf M:
Ischemic preconditioning augments survival of stem cells via
miR-210 expression by targeting caspase-8-associated protein 2. J
Biol Chem. 284:33161–33168. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Carroll WL, Bhojwani D, Min DJ, Raetz E,
Relling M, Davies S, Downing JR, Willman CL and Reed JC: Pediatric
acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ
Program. 102–131. 2003.PubMed/NCBI
|
|
17
|
Wang KL, Mei YY, Cui L, Zhao XX, Li WJ,
Gao C, Liu SG, Jiao Y, Liu FF, Wu MY, et al: E2F3a gene expression
has prognostic significance in childhood acute lymphoblastic
leukemia. Eur J Haematol. 93:281–289. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rieu I and Powers SJ: Real-time
quantitative RT-PCR: Design, calculations, and statistics. Plant
Cell. 21:1031–1033. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pallisgaard N, Clausen N, Schroder H and
Hokland P: Rapid and sensitive minimal residual disease detection
in acute leukemia by quantitative real-time RT-PCR exemplified by
t(12;21) TEL-AML1 fusion transcript. Genes Chromosomes Cancer.
26:355–365. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gao C, Zhao XX, Li WJ, Cui L, Zhao W, Liu
SG, Yue ZX, Jiao Y, Wu MY and Li ZG: Clinical features, early
treatment responses, and outcomes of pediatric acute lymphoblastic
leukemia in China with or without specific fusion transcripts: A
single institutional study of 1,004 patients. Am J Hematol.
87:1022–1027. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mortensen BT, Jensen PO, Helledie N,
Iversen PO, Ralfkiaer E, Larsen JK and Madsen MT: Changing bone
marrow micro-environment during development of acute myeloid
leukaemia in rats. Br J Haematol. 102:458–464. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang H, Luo XQ, Zhang P, Huang LB, Zheng
YS, Wu J, Zhou H, Qu LH, Xu L and Chen YQ: MicroRNA patterns
associated with clinical prognostic parameters and CNS relapse
prediction in pediatric acute leukemia. PLoS One. 4:e78262009.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Qin Q, Furong W and Baosheng L: Multiple
functions of hypoxia-regulated miR-210 in cancer. J Exp Clin Cancer
Res. 33:502014. View Article : Google Scholar : PubMed/NCBI
|
